Clinical Trials Browser

Phase 2 × INDUSTRY × Hyperuricemia × Clear all

NCT00664144 2012-03-07

GRAAL2

Phase 2 Terminated

Hyperuricemia

NCT00631579 2009-10-02

Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Hyperuricemia

NCT00290992 2009-03-30

Rasburicase for Hyperuricemia

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Nutritional and Metabolic Diseases, Hyperuricemia